Pioglitazone (AD-4833) Ameliorates Insulin Resistance in Patients with NIDDM.-Reference-Cited by-同舟云学术

Pioglitazone (AD-4833) Ameliorates Insulin Resistance in Patients with NIDDM.

Published:1997 Issue:3 Volume:183 Page:173-183
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Yamasaki Yoshimitsu¹,Kawamori Ryuzo²,Wasada Taro³,Sato Akiko³,Omori Yasue³,Eguchi Hideyuki⁴,Tominaga Makoto⁴,Sasaki Hideo⁵,Ikeda Masahiko¹,Kubota Minoru¹,Ishida Yoshihiko⁵,Hozumi Toshiki⁵,Baba Shigeaki⁵,Uehara Masaya⁶,Shichiri Motoaki⁶,Kaneko Toshio⁷,Ad-4833 Glucose Clamp Study Group, Japan

Affiliation:

1. The First Department of Medicine, Osaka University Medical School

2. Department of Medicine, Juntendo University, School of Medicine

3. Department of Medicine, Tokyo Women's Medicine College

4. Department of Medicine, Yamagata University, School of Medicine

5. Department of Medicine, Hyogo Medical Center for Adults

6. Department of Medicine, Kumamoto University, Medical School

7. Yamaguchi Rosai Hospital

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine